Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$402K Hold
222
– – 0.18% 137
2026
Q2
$442K Hold
222
– – 0.19% 127
2026
Q1
$293K Buy
+222
New +$304K 0.15% 149
2024
Q3
– Sell
-1
Closed -$1.02K – 568
2024
Q2
$1.02K Sell
1
-8
-89% -$7.69K ﹤0.01% 807
2024
Q1
$8.73K Hold
9
– – ﹤0.01% 551
2023
Q4
$6.81K Sell
9
-13
-59% -$8.58K ﹤0.01% 547
2023
Q3
$13K Hold
22
– – 0.01% 402
2023
Q2
$15.9K Buy
22
+11
+100% +$7.48K 0.01% 384
2023
Q1
$7.49K Buy
11
+8
+267% +$5.14K 0.01% 454
2022
Q4
$1.64K Hold
3
– – ﹤0.01% 523
2022
Q3
$1K Hold
3
– – ﹤0.01% 553
2022
Q2
$1.43K Buy
+3
New +$1.68K ﹤0.01% 658
2021
Q2
$96K Buy
+139
New +$91.7K 0.04% 293

Other funds holding ASML

Castleview Partners's ASML Position: Q3 2026 in Review

Castleview Partners held its ASML (ASML) position steady in Q3 2026 at 222 shares worth $402K. The position accounts for 0.18% of the portfolio, ranked #137.

Castleview Partners first reported a position in ASML in Q2 2021 and has held it in 13 quarters since. The position peaked at $442K in Q2 2026. 118 funds tracked by Wall St. Rank hold ASML as of Q3 2026.

  • Castleview Partners held 222 shares of ASML worth $402K as of Q3 2026.
  • Castleview Partners left its ASML share count unchanged in Q3 2026.
  • ASML made up 0.18% of Castleview Partners's portfolio in Q3 2026, its #137 holding.
  • Castleview Partners first reported a position in ASML in Q2 2021 and has held it in 13 quarters since.
  • Castleview Partners's ASML position peaked at $442K in Q2 2026.
  • 118 funds tracked by Wall St. Rank held ASML as of Q3 2026.

Based on Castleview Partners's 13F filing for Q3 2026, filed 9 Oct 2026.